How to Sell a Psychiatry Practice

Psychiatry Practices

How to Sell a Psychiatry Practice — The Complete Guide

Selling a psychiatry practice is one of the most significant financial and professional decisions a psychiatrist makes. It is also one of the most misunderstood.

Most psychiatrists who own a practice have never sold one before. The buyers approaching them do this for a living. Without preparation, without a clear picture of what the psychiatry practice is worth, and without a structured process that creates competitive pressure — the psychiatrist is at a significant disadvantage before the first conversation begins.

I founded Olympic M&A to give psychiatry practice owners the same level of representation that institutional buyers enjoy. Today the firm advises psychiatrists across the United States — from solo practitioners running outpatient psychiatry practices to multi-psychiatrist groups with TMS, Spravato, and telepsychiatry service lines — through the entire process of selling a psychiatry practice on terms the seller is proud of.

This is the complete guide to how to sell a psychiatry practice — from understanding your value, to running a process, to closing on terms you control.

Tony Siebel — Founder & Managing Director, Olympic M&A

Top 50 M&A Advisors 2025 · $70M+ in completed healthcare M&A transactions · 60+ published articles on healthcare consolidation · Specialized advisor for psychiatry practice sellers

Why Selling a Psychiatry Practice Is Different from Selling Any Other Medical Practice

In a conventional medical practice the buyer is primarily evaluating collections, referral channels, provider productivity, staffing, and payer mix. In a psychiatry practice those factors matter — but they are not the whole story.

The buyer of a psychiatry practice is also evaluating:

Reimbursement durability under the Mental Health Parity and Addiction Equity Act final rule, which has materially improved psychiatric reimbursement compared to a decade ago
Telepsychiatry penetration — the percentage of your psychiatry visits already delivered virtually, and how that scales geographically
Controlled-substance prescribing protocols and your practice's DEA registration compliance posture
Psychiatrist productivity per FTE — measured in completed visits, RVUs, and net collections per psychiatrist
Founder dependency risk — whether your patients are loyal to the practice or to one psychiatrist personally
Service-line mix — outpatient medication management vs. TMS vs. Spravato vs. psychiatric testing — each affects your psychiatry multiple differently
Credentialing and payer contract transferability — buyers underwrite how cleanly your psychiatry payer contracts move through closing

A psychiatry practice is not just a clinical asset. It is a knowledge-driven, reimbursement-protected, telehealth-native specialty business operating in the most undersupplied corner of American medicine.

That distinction matters more than most psychiatrists realize. Two psychiatry practices with identical revenue can produce dramatically different sale outcomes based on how transferable that revenue is, how clean the financials are, and how the practice is positioned to a sophisticated buyer.

The best way to sell a psychiatry practice is not to find a buyer and name a price. It is to prepare the psychiatry practice so the right buyer sees durable revenue, manageable transition risk, and a patient base that can stay engaged through change.

Step 1 — Understand What Your Psychiatry Practice Is Worth Before Any Buyer Conversation

The first step in how to sell a psychiatry practice is getting a clear, honest picture of what your practice is worth in today's market. Not based on what you think it should be worth. Not based on what a colleague sold for three years ago. Based on what sophisticated psychiatry buyers are actually paying right now for practices with your specific psychiatrist count, payer mix, telepsychiatry penetration, and service-line composition.

Psychiatry practice valuations in 2026 break down roughly as follows:

Solo psychiatrist practices with clean fundamentals typically transact in the 5x to 6.6x range on normalized EBITDA
Multi-psychiatrist groups (3–10 psychiatrists) with operational depth typically transact in the 5.5x to 7x range
Platform-scale psychiatry practices ($2M+ EBITDA, multi-location, TMS-dense, or with proprietary technology) can move into the 7x to 10x+ range in a competitive process

A $200,000 improvement in documented psychiatry practice EBITDA multiplied by a 6x multiple equals $1.2 million in additional enterprise value. Small improvements to your fundamentals — financial documentation, owner dependency, payer mix data, telepsychiatry reporting — can materially change what your psychiatry practice is worth before you ever go to market.

LEARN MORE — Psychiatry Practice Valuation: What Drives Value In 2026

A deeper walkthrough of how the EBITDA number itself gets built.

Step 2 — Prepare the Psychiatry Practice Before You Go to Market

The psychiatrists who achieve the strongest outcomes in psychiatry practice transactions almost always started preparing 12 to 24 months before going to market. Here are the preparation steps that most directly affect your outcome.

Clean Your Financial Documentation

Three years of organized financial statements. Clear separation of psychiatry revenue by service line (medication management, TMS, Spravato, psychiatric testing, telepsychiatry). Documented psychiatrist compensation. Normalized add-backs with clear explanations. Current-year monthly reporting.

Buyers pay a premium for psychiatry practices where the financial story is clear and credible. They discount practices where financials are unclear or require extensive explanation.

Address Owner Dependency

Owner dependency is the single most common valuation problem in psychiatry practice transactions. If patients stay primarily because of your personal relationships — and might leave when you step back — buyers price that transition risk into every offer.

Reducing owner dependency in a psychiatry practice before going to market means building team-based clinical care, introducing additional psychiatrists or psychiatric nurse practitioners into the patient experience, and standardizing prescribing protocols across providers. This takes time and produces significant valuation impact.

Build Your Psychiatry Practice Performance Package

Have your operational data organized and readily accessible before any buyer asks:

Active patient panel size per psychiatrist
Visits per psychiatrist per week
Payer mix percentages (commercial / Medicare / Medicaid / self-pay)
Net collections per visit by CPT code (90792, 99214, 99215, 90833, 90834, 90837, TMS 90867–90869)
Telepsychiatry penetration as a percentage of total visits
New patient wait time
Patient retention / no-show rates
TMS or Spravato course completion rates if applicable

A psychiatrist who can present this data cleanly and confidently is demonstrating that the psychiatry practice's most important assets are being managed systematically.

Clean Up Compliance and Credentialing

Buyers will diligence:

DEA registrations for every prescribing provider
State psychiatric licenses and any pending issues
Controlled-substance prescribing protocols and any state-level monitoring program (PDMP) compliance
Telepsychiatry compliance with state-by-state regulations
Payer credentialing files and contract assignability
HIPAA program documentation

Sloppy compliance documentation does not just lower your psychiatry practice multiple — it can collapse a deal during diligence.

Decide What Transition You Actually Want

Will you stay on post-close? For how long? In what role? What are your non-negotiables around prescribing autonomy, visit length, and the psychiatrist-patient relationship?

Knowing the answers to these questions before going to market is what allows you to evaluate buyers against a clear picture of what a good outcome looks like for you specifically.

LEARN MORE — Preparing Your Psychiatry Practice for Sale

The complete preparation guide with the specific steps that protect your psychiatry practice value.

Download — 2026 Psychiatry Practice Market Update — Free

Current PE buyer activity, deal structures, and the platform-acquisition data shaping psychiatry M&A right now.

Step 3 — Understand Who Is Buying Psychiatry Practices Right Now

There is no single buyer profile for a psychiatry practice. Understanding who is approaching your market — and what each buyer type specifically wants — is one of the most important things you can know before any conversation begins.

Private Equity-Backed Psychiatry Platforms

The most active buyer category in psychiatry M&A. PE-backed psychiatry platforms — including LifeStance Health, Mindpath Health, Talkiatry, Octave, Brightside, Headway, and ARC Health — are acquiring independent psychiatry practices to scale their psychiatry footprint nationally. They move quickly, they have done their homework before they call you, and they tend to pay the highest psychiatry practice multiples — particularly for practices with multiple psychiatrists, strong commercial payer mix, and demonstrable telepsychiatry capability.

Strategic Payer Buyers

Several large insurers and integrated delivery systems have built or acquired psychiatry capability to manage utilization, capture reimbursement spread, and meet parity-driven psychiatric service expectations. Strategic payer buyers tend to value scale and geographic psychiatry coverage. They are not always the fastest movers but they often pay competitively for the right psychiatry asset.

Physician-Owned Psychiatry Platforms

Psychiatrist-led psychiatry groups expanding through acquisition. These buyers often offer the best cultural fit for psychiatrist-sellers who want their practice to remain physician-led after closing. Multiples are typically slightly below PE psychiatry platforms but the post-close clinical experience can be meaningfully better for the seller and the patients.

Family Offices and Long-Term Hold Capital

A smaller but growing category in psychiatry M&A. Family offices acquiring psychiatry practices as long-duration healthcare assets with predictable cash flow. Less common at the smaller end of the psychiatry market, more relevant for $2M+ EBITDA psychiatry practices.

Hospital Systems and Academic Psychiatry Departments

Less competitive on price but relevant for psychiatrists who prioritize academic affiliation, integration with broader medical care, or specific community-mission alignment.

The right buyer for your psychiatry practice is not necessarily the one with the highest first offer. It is the buyer whose model, values, and long-term vision align most closely with what you built. The best way to sell a psychiatry practice is to run a process that brings multiple qualified psychiatry buyers to the table — so you are choosing rather than accepting.

LEARN MORE — Why Private Equity Firms Buy Psychiatry Practices

The insider perspective on what PE firms specifically look for in psychiatry — and what that means for your valuation.

LEARN MORE — What Buyers Look for When Evaluating Your Psychiatry Practice

Exactly what buyers score before they make an offer on your psychiatry practice — from the buyer’s perspective.

Step 4 — Run a Structured Competitive Process

The single most important thing that separates a good outcome from a great one in a psychiatry practice transaction is the process. Not the market. Not the size of the practice. The process.

A structured competitive process means identifying and qualifying multiple psychiatry buyers simultaneously — not responding to whoever calls first. It means running a confidential outreach to a curated list of psychiatry buyers who are the right fit for your practice. It means creating genuine competitive pressure so that buyers are pricing against each other rather than against your isolation.

A well-run psychiatry practice transaction takes 9 to 12 months from market engagement to close. The full timeline from preparation through close typically runs 18 to 30 months for psychiatrists who prepare properly. Psychiatrists who try to compress this timeline sacrifice leverage at every stage.

The Six-Step Psychiatry Practice Sale Process

Step 1 — Valuation and readiness assessment.

Understand where your psychiatry practice stands before going to market. Identify the improvements that would most meaningfully affect your outcome.

Step 2 — Prepare market-facing materials.

Confidential information memorandum. Psychiatry practice narrative. Financial highlights. Psychiatrist productivity and payer mix data. Service-line breakdown (medication management, TMS, Spravato, telepsychiatry). Growth thesis.

Step 3 — Targeted psychiatry buyer outreach.

Confidential approach to a curated list of qualified psychiatry buyers. Not a public listing. A private process that protects your practice and your patients while creating genuine competitive pressure.

Step 4 — Evaluate offers beyond headline value.

Cash at close. Earnout structure. Rollover equity. Transition expectations. Employment terms. Prescribing autonomy commitments. Patient care standards. Cultural fit. The headline number is only one piece of the evaluation.

Step 5 — Manage diligence.

Financial statements. Payer contracts. DEA registrations. State psychiatric licenses. Compliance documentation. Patient and staffing data. EMR access. This is where sloppy preparation unravels deals.

Step 6 — Execute the transition carefully.

In psychiatry, communication strategy is not cosmetic. It is deal protection. How you communicate the transition to your patients and your team directly affects whether they stay through it.

Step 5 — Protect What Matters Most Through the Transaction

The psychiatrists who end up proud of their psychiatry practice transaction outcome are not always the ones who achieved the highest number. They are the ones who protected what mattered most — their patients, their team, their prescribing philosophy, and their own integrity through the process.

The right psychiatry buyer is not just the highest bidder. It is the buyer whose model, values, and long-term vision align with what you built. A buyer who sees your psychiatry practice as a revenue stream to optimize will behave very differently after close than a buyer who sees it as a clinical philosophy worth preserving.

Specific things to protect through a psychiatry practice transaction:

Prescribing autonomy — particularly around controlled substances, complex polypharmacy, and patient-specific protocols you have built over years
Visit length and clinical model — many PE buyers expect productivity standardization; the right buyer respects what you have built
Patient care continuity — particularly for long-tenured patients with complex psychiatric conditions
Staff retention — your medical assistants, prescribing nurses, billing team, and front-office staff often hold meaningful patient relationships
Your post-close role — clearly defined, contractually documented, and aligned with the next chapter you actually want

A well-run competitive process with multiple qualified psychiatry buyers gives you the leverage to choose. A single unsolicited offer with no competitive pressure leaves the choice to the buyer.

LEARN MORE — Consolidation Trends in Psychiatry — What Practice Owners Need to Know Right Now

Why the psychiatry consolidation wave is happening now and what it means for your practice.

How Olympic M&A Approaches a Psychiatry Practice Transaction

Olympic M&A is a specialized M&A advisory firm serving psychiatry practice owners in the lower middle market. We represent psychiatrist sellers — never buyers — across outpatient psychiatry practices, TMS-focused psychiatry practices, child and adolescent psychiatry practices, and multi-psychiatrist groups.

We work on a success-fee model — we get paid when your psychiatry practice deal closes. We do not charge retainers or preparation fees.

We are also one of the only M&A firms offering pre-exit advisory services that prepare psychiatry practice owners 12 to 24 months before they ever go to market. The Psychiatry Practice Exit Readiness Review gives you a clear picture of what your practice is worth today, what is driving or limiting that value, and the specific steps to strengthen your position before any transaction conversation begins.

FAQ — How to Sell a Psychiatry Practice

How do I sell my psychiatry practice?

Start with a clear picture of what your psychiatry practice is worth in today's market. Then prepare the practice — clean financial documentation, reduced owner dependency, organized payer mix and psychiatrist productivity data, compliant DEA and state-licensure documentation. Then engage a specialized advisor who understands the psychiatry buyer universe specifically. Then run a structured competitive process with multiple qualified psychiatry buyers. The best way to sell a psychiatry practice is deliberate not rushed — the full process from serious preparation through funded close typically takes 18 to 30 months for psychiatrists who optimize their outcome.

How long does it take to sell a psychiatry practice?

A well-run process takes 9 to 12 months from market engagement to close. Preparation before going to market takes an additional 12 to 24 months for psychiatrists who want to optimize their outcome. The psychiatrists who achieve the strongest results plan for an 18 to 30 month total timeline. Psychiatrists who try to compress this timeline sacrifice leverage at every stage — in preparation, in buyer selection, and in negotiation.

What is my psychiatry practice worth?

A well-prepared solo psychiatry practice typically supports valuations in the 3.5x to 5.5x range on normalized EBITDA. A multi-psychiatrist group (3–10 psychiatrists) with operational depth typically transacts in the 5x to 7x range. A platform-scale psychiatry practice with $2M+ EBITDA, multi-location operations, or significant TMS density can move into the 7x to 10x+ range in a competitive process. Two psychiatry practices with similar revenue can have very different valuations based on payer mix, telepsychiatry penetration, owner dependency, financial documentation quality, and growth potential. A $200,000 improvement in documented EBITDA at a 6x multiple equals $1.2 million in additional enterprise value — which is why preparation directly affects what buyers will pay. Use the Psychiatry Practice Valuation Calculator for an immediate estimate.

Who buys psychiatry practices?

Five categories of buyers are actively evaluating psychiatry practices right now. Private equity-backed psychiatry platforms acquiring practices to build national scale. Strategic payer buyers and integrated delivery systems building or acquiring psychiatry capability. Physician-owned psychiatry platforms led by other psychiatrists and expanding through acquisition. Family offices acquiring psychiatry practices as long-duration healthcare assets. Hospital systems and academic psychiatry departments evaluating practices for community integration. The right buyer for your psychiatry practice depends on your transition goals, your prescribing philosophy, and what you want the practice to look like after you step back.

Do I need a psychiatry practice broker or M&A advisor?

Yes — and the advisor matters significantly. Not all M&A advisors understand the psychiatry model specifically. The buyer universe, the valuation drivers, the reimbursement dynamics, the controlled-substance compliance issues, the telepsychiatry regulations, and the transition dynamics in psychiatry are different from standard medical practice sales. An advisor without psychiatry-specific experience will not know how to position your practice, identify the right psychiatry buyers, or structure a process that maximizes competitive pressure.

What is the best way to sell a psychiatry practice?

Prepare early. Understand your psychiatry practice value before any buyer conversation begins. Run a structured competitive process with multiple qualified psychiatry buyers. Choose the buyer whose model, values, and long-term vision align with what you built — not just the one with the highest first number. The psychiatrists who achieve the strongest outcomes are not the ones who moved fastest or accepted the first offer. They are the ones who gave themselves time to prepare, ran a process that created genuine leverage, and walked into every conversation knowing exactly what their psychiatry practice was worth and what they were trying to protect.

How do I know if an offer for my psychiatry practice is fair?

You cannot evaluate an offer fairly without a clear picture of what your psychiatry practice is worth in today's market based on current buyer activity and comparable psychiatry transactions. A psychiatrist who receives an offer without this context has no framework to evaluate whether the number is fair, low, or worth countering. Getting a formal valuation assessment before any buyer conversation begins — and engaging a specialized advisor who knows what comparable psychiatry practices are transacting at — is the most direct way to ensure you can evaluate any offer on its actual merits.

What lowers the value of a psychiatry practice in a sale?

Heavy founder concentration where patients are tied to one psychiatrist personally. Weak or unclear financial documentation. Aggressive or undocumented add-backs that buyers cannot defend in diligence. A heavily Medicaid-concentrated payer mix without offsetting volume. Low telepsychiatry penetration in a market where buyers expect virtual capability. Compliance gaps in DEA registrations, controlled-substance protocols, or telepsychiatry licensure. Flat or declining patient volume with no credible growth thesis.

Should I sell my psychiatry practice to private equity?

Maybe. PE-backed psychiatry buyers tend to pay the highest multiples and offer the most competitive terms — particularly for multi-psychiatrist practices with strong commercial payer mix. They also bring expectations around productivity, operational standardization, and growth that may or may not align with what you want your practice to look like post-close. The right answer depends on your transition goals, your tolerance for clinical-model change, and the specific PE buyer's track record with psychiatry sellers. A competitive process that includes both PE and non-PE buyers gives you the data to make that decision on your own terms.

About Tony Siebel

Founder & Managing Director, Olympic M&A

Tony Siebel is the Founder & Managing Director of Olympic M&A and one of the country's most active healthcare practice M&A advisors. Named to the Top 50 M&A Advisors of 2025, Tony has personally led more than $70M in completed healthcare M&A transactions and authored 60+ articles on healthcare practice valuation, sale readiness, and structured competitive sale processes.

Tony's expertise in the psychiatry and TMS industry is unparalleled. He understood our practice, our patients, and our growth story — and ran a process that delivered a result well above what other advisors had quoted us. He is the advisor I recommend to any psychiatrist thinking about a sale.

— Brian E., MD · Psychiatry Practice Owner

Tony advises psychiatry practice owners across the U.S. on practice valuation, sale preparation, buyer selection, and deal execution — always with the same goal: a confidential, competitive process that delivers the best possible outcome for the owner and the practice.

olympicma.com | tonys@olympicma.com | 502.360.8320

Join the Webinar — The Truth About Selling Your Psychiatry Practice in 2026–2027

A live, confidential webinar for psychiatry practice owners exploring what comes next. Insider perspective on valuation, buyer types, and how to protect what you've built. No pressure, no prep needed.